Sentinal4D Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.23M

  • Investors
  • 7

Sentinal4D General Information

Description

Developer of a biotechnology platform designed to advance 3D (three-dimensional) cell-based drug screening and improve understanding of how drugs affect cellular behavior. The company offers unique 3D and 4D (four-dimensional) cellular datasets and AI (artificial intelligence) software that analyses the shape and structure of single cells in three dimensions, enabling pharmaceutical partners to understand drug mechanisms, detect off-target effects, and prioritise promising therapies earlier in development, enabling patients with cancer, neurodegenerative diseases, and chronic inflammatory syndromes to receive personalized therapeutics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 221 Pentonville Road
  • London N1 9UZ
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 221 Pentonville Road
  • London N1 9UZ
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sentinal4D Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 14-Jan-2025 $1.23M Completed Startup
2. Accelerator/Incubator 01-Jan-2022 Completed Startup
1. Accelerator/Incubator 01-Jan-2022 Completed Startup
To view Sentinal4D’s complete valuation and funding history, request access »

Sentinal4D Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
To view Sentinal4D’s complete cap table history, request access »

Sentinal4D Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology platform designed to advance 3D (three-dimensional) cell-based drug screening and improve u
Drug Discovery
London, United Kingdom
7 As of 2026

South San Francisco, CA
 

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sentinal4D Competitors (6)

One of Sentinal4D’s 6 competitors is insitro, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
insitro Venture Capital-Backed South San Francisco, CA
Phenomic AI Venture Capital-Backed Toronto, Canada
Owkin Venture Capital-Backed Paris, France
Recursion Pharmaceuticals Formerly VC-backed Salt Lake City, UT
Alpenglow Biosciences Venture Capital-Backed Seattle, WA
To view Sentinal4D’s complete competitors history, request access »

Sentinal4D Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sentinal4D Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arben Ventures Venture Capital Minority
Twin Path Ventures Venture Capital Minority
Cancer Research Technology Venture Capital Minority
Cancer Tech Accelerator Accelerator/Incubator Minority
Capital Research UK Other Minority
You’re viewing 5 of 7 investors. Get the full list »

Sentinal4D FAQs

  • When was Sentinal4D founded?

    Sentinal4D was founded in 2024.

  • Where is Sentinal4D headquartered?

    Sentinal4D is headquartered in London, United Kingdom.

  • What is the size of Sentinal4D?

    Sentinal4D has 7 total employees.

  • What industry is Sentinal4D in?

    Sentinal4D’s primary industry is Drug Discovery.

  • Is Sentinal4D a private or public company?

    Sentinal4D is a Private company.

  • What is the current valuation of Sentinal4D?

    The current valuation of Sentinal4D is .

  • What is Sentinal4D’s current revenue?

    The current revenue for Sentinal4D is .

  • How much funding has Sentinal4D raised over time?

    Sentinal4D has raised $1.32M.

  • Who are Sentinal4D’s investors?

    Arben Ventures, Twin Path Ventures, Cancer Research Technology, Cancer Tech Accelerator, and Capital Research UK are 5 of 7 investors who have invested in Sentinal4D.

  • Who are Sentinal4D’s competitors?

    insitro, Phenomic AI, Owkin, Recursion Pharmaceuticals, and Alpenglow Biosciences are some of the 6 competitors of Sentinal4D.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process